» Articles » PMID: 19897773

Combined Effects of Obesity and Chronic Obstructive Pulmonary Disease on Dyspnea and Exercise Tolerance

Overview
Specialty Critical Care
Date 2009 Nov 10
PMID 19897773
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Severity of lung hyperinflation is known to influence the extent of dyspnea and exercise intolerance among patients with chronic obstructive pulmonary disease (COPD) with similar degrees of airway obstruction. Lung volume components are consistently affected by body mass index (BMI) in health and in disease.

Objectives: To explore the complex interactions between obesity, lung hyperinflation, dyspnea, and exercise performance in COPD.

Methods: We compared dyspnea intensity ratings and ventilatory responses (breathing pattern, operating lung volumes, and gas exchange) during symptom-limited incremental cycle exercise in well-characterized groups of 18 obese (mean BMI +/- SD, 35 +/- 4 kg/m(2)) and 18 normal-weight (mean BMI +/- SD, 22 +/- 2 kg/m(2)) patients with moderate to severe COPD.

Measurements And Main Results: Groups were well matched for FEV(1) (mean 49% predicted) and diffusing capacity (means >70% predicted), but resting lung hyperinflation (end-expiratory lung volume [EELV]) was significantly reduced in association with increasing BMI (P < 0.005). In the obese patients, peak symptom-limited oxygen uptake was increased (P < 0.01) and dyspnea ratings at a standardized ventilation were decreased (P < 0.01) compared with normal-weight patients. Ratings of dyspnea intensity at a standardized ventilation during exercise correlated well with the concurrent dynamic EELV/total lung capacity (TLC) ratio (r = 0.68; P < 0.00001) and with the resting EELV/TLC (r = 0.67; P < 0.00001).

Conclusions: The combined mechanical effects of obesity and COPD reduced operating lung volumes at rest and throughout exercise with favorable influences on dyspnea perception and peak oxygen uptake during cycle ergometry.

Citing Articles

The effect of expiratory flow limitation on supine persistent hyperinflation in COPD: a prospective observational study.

Srinivasan M, Pollard H, Chapman D, Tonga K, Patel K, Blokland K ERJ Open Res. 2024; 10(6).

PMID: 39588072 PMC: 11587055. DOI: 10.1183/23120541.00255-2024.


Malnutrition and Obesity in Patients with COPD Exacerbation, Insights from the National Inpatient Sample.

El Labban M, El-Zibaoui R, Usama S, Niaz F, Cohen A, Krastev P Open Respir Med J. 2024; 18:e18743064322829.

PMID: 39450126 PMC: 11499682. DOI: 10.2174/0118743064322829240801094830.


Obesity Impact on Dyspnea in COPD Patients.

Dupuis A, Thierry A, Perotin J, Ancel J, Dormoy V, Dury S Int J Chron Obstruct Pulmon Dis. 2024; 19():1695-1706.

PMID: 39070800 PMC: 11277818. DOI: 10.2147/COPD.S450366.


Body mass index affects spirometry indices in patients with chronic obstructive pulmonary disease and asthma.

Wang X, Gan H, Wang Y, Yu X, An J, Sun B Front Physiol. 2023; 14:1132078.

PMID: 38107480 PMC: 10722288. DOI: 10.3389/fphys.2023.1132078.


Hyperglycaemia and Chronic Obstructive Pulmonary Disease.

Cazzola M, Rogliani P, Ora J, Calzetta L, Lauro D, Matera M Diagnostics (Basel). 2023; 13(21).

PMID: 37958258 PMC: 10650064. DOI: 10.3390/diagnostics13213362.